Stallion India Fluorochemicals Limited has informed the Exchange regarding a press release dated August 08, 2025, titled "Strong Q1FY25-26 Performance in Line with Growth Guidance; On Track to Achieve FY25-26 Targets".
STALLION · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Stallion India Fluorochemicals reported strong Q1 FY25-26 results with total revenue rising 50.30% YoY to ₹11,054.55 lakhs from ₹7,355.17 lakhs. EBITDA grew 12.73% to ₹1,436.94 lakhs, while profit before tax (PBT) increased 22.56% to ₹1,386.14 lakhs and profit after tax (PAT) rose 21.47% to ₹1,036.32 lakhs. Despite the strong topline, EBITDA margin contracted as EBITDA growth lagged significantly behind revenue growth. Management noted that the April border conflict and early monsoon onset in May negatively impacted sales and margins, and added that Q1 and Q2 are seasonally weaker quarters, with stronger performance expected in Q3 and Q4. The company reaffirmed it is on track to meet FY25-26 growth targets.
Positive headline revenue growth supports the growth story, but the sharp drop in EBITDA margin (from ~17.3% to ~13.0%) signals cost or pricing pressure that investors should watch closely. Near-term sentiment may be supported by management's confidence in meeting full-year targets, though the weak seasonal quarters and external headwinds could keep volatility high.